# Urban Datalab Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/urban-datalab-co

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.urbandatalab.co.kr/
- Total disclosed funding: $1.8M
- Latest round: Series A (Jul 30, 2025)
- Investors on record: 4

## About

Urban Datalab Co., Ltd. is an innovative company that specializes in AI-driven healthcare solutions, developing advanced technologies to enhance medical data processing and utilization in the healthcare sector. Urban Datalab Co., Ltd. is focused on creating a cloud-based artificial intelligence medical platform that aims to improve healthcare delivery. Founded in 2019 in Seoul, South Korea, the company has successfully completed five deals as of September 2025. The founder has a background in technology and healthcare innovation, although specific details about previous ventures are not available. Urban DataLab specializes in AI-driven healthcare solutions, focusing on the development of a cloud-based artificial intelligence medical platform. Their core offerings include advanced technologies in natural language processing, image recognition, and data platform services designed to enhance the digital healthcare ecosystem. The healthcare solutions facilitate the collection, processing, and utilization of medical data, addressing the needs of healthcare providers and practitioners. Additionally, Urban DataLab organizes hackathons to drive innovation in AI applications, enabling participants to create practical AI models that tackle social issues. This suite of services is targeted at healthcare institutions and organizations primarily in South Korea, with aspirations to reach broader international markets. Urban DataLab generates revenue through a subscription model and strategic partnerships with healthcare providers and organizations. Clients typically engage in contracts that grant them access to Urban DataLab’s AI solutions and data analytics capabilities, allowing them to optimize their healthcare services. Revenue transactions are structured around long-term agreements, where clients pay for ongoing access to the platform and its associated services. The company’s flagship products, including its healthcare data platform and AI analytics tools, are critical to its revenue stream, ensuring that clients receive continuous support and updates tailored to their operational needs. The pricing structure accommodates various scales of operation, ensuring that both large institutions and smaller healthcare facilities can benefit from their innovative solutions. Urban Datalab Co., Ltd. plans to launch new AI healthcare products by late 2025, aimed at enhancing patient data analysis capabilities. The company is also focused on expanding its market presence beyond South Korea, targeting regions in Southeast Asia and North America by 2026.

## Funding rounds

- Series A, Jul 30, 2025, $1.8M — The Invention Lab, NAVER Cloud Corp., BDC Labs, Aseptic Inc.

## Investors

- The Invention Lab (https://capitalatlas.ai/funds/the-invention-lab) — Series A
- NAVER Cloud Corp. — Series A
- BDC Labs — Series A
- Aseptic Inc. — Series A